Article

2 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

  • You can purchase this item in Pay Per ViewPay per View - FAQ : 30,00 € Taxes included to order
    Pages Iconography Videos Other
    4 2 0 0


Joint Bone Spine
Volume 79, n° 2
pages 109-112 (mars 2012)
Doi : 10.1016/j.jbspin.2011.11.004
accepted : 9 November 2011
Should anti-TNF-⍺ drug levels and/or anti-drug antibodies be assayed in patients treated for rheumatoid arthritis?
 

Denis Mulleman a, 1, , b , Emilie Ducourau a, b, 1, Gilles Paintaud a, 1, David Ternant a, c, 1, Hervé Watier a, d, 1, Philippe Goupille a, b, c, 1
a Équipe « Anticorps, récepteurs Fc et réponses cliniques », laboratoire d’Excellence MAbImprove, CNRS UMR 7292, université François-Rabelais de Tours, 3, rue des Tanneurs, 37041 Tours cedex 1, France 
b Service de rhumatologie, CHRU de Tours, 37044 Tours cedex 9, France 
c Laboratoire de pharmacologie-toxicologie et centre pilote de suivi biologique des anticorps thérapeutiques (CePiBAc), CHRU de Tours, 37044 Tours cedex 9, France 
d Laboratoire d’mmunologie et centre pilote de suivi biologique des anticorps thérapeutiques (CePiBAc), CHRU de Tours, 37044 Tours cedex 9, France 

Corresponding author. Tel.: +33 47 47 59 17; fax: +33 47 47 46 39.

Keywords : Biopharmaceuticals, Monoclonal antibodies, Rheumatoid arthritis, Therapeutic drug monitoring, Immunogenicity




© 2012  Published by Elsevier Masson SAS.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline